Taiwan FDA registration 56b0925bcc85b5f311c1d38e96de6ef0
Abbott Drug Abuse Test Group - Negative Correction Solution Group
TW: 亞培藥物濫用檢驗試劑組-陰性校正液組
Taiwan·Risk Class 2·MICROGENICS CORPORATION·Registered Sep 25, 2020 – Sep 25, 2025ExpiredRegistration details
- Analysis ID
- 56b0925bcc85b5f311c1d38e96de6ef0
- Customs Code
- DHA05603367900
Company information
- Manufacturer
- MICROGENICS CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product is used on the Alinity c analyzer to correct the detection of amphetamine/methamphetamine, barbiturates, cannabinoids, cocaine metabolites, ecstasy, methadone, Opiates, phencyclidine and propoxyphene drug of abuse (DOA) analysis.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 Calibrated Products
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Sep 25, 2020
- Expiry Date
- Sep 25, 2025
About this record
Access comprehensive regulatory information for Abbott Drug Abuse Test Group - Negative Correction Solution Group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 56b0925bcc85b5f311c1d38e96de6ef0 and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices